The impact of time and day on the presentation of acute coronary syndromes

被引:52
|
作者
LaBounty, Troy
Eagle, Kim A.
Manfredini, Roberto
Fang, Jianming
Tsai, Thomas
Smith, Dean
Rubenfire, Melvyn
机构
[1] Univ Michigan, Michigan Cardiovasc Outcomes Res & Reporting Prog, Div Cardiovasc Med, Dept Internal Med,Med Ctr, Ann Arbor, MI 48106 USA
[2] Univ Ferrara, I-44100 Ferrara, Italy
关键词
acute coronary syndrome; circadian pattern; circaseptan pattern; acute myocardial infarction; unstable angina;
D O I
10.1002/clc.22
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The frequency of acute myocardial infarction (AMI) peaks on Mondays and in the mornings. However, the distribution of the types of acute coronary syndromes (ACS), including unstable angina (UA), has not been systematically evaluated. Hypothesis: The distribution of the types of ACS and clinical presentations varies by time and day of admission. Methods: A retrospective cohort study was conducted in 1,946 consecutive nontransfer ACS admissions (1999-2004) to a tertiary-care academic center to assess presenting clinical variables in patients admitted on days versus nights (6 P.M.-6 A.M.) and weekdays versus weekends (Friday 6 P.M.-Monday 6 A.M.). Results: There were fewer ACS admissions than expected on nights and weekends (p < 0.001), but the proportion of patients with ACS presenting with ST-elevation myocardial infarction (STEMI) is 64% higher on weekends (p < 0.001) and 31% higher on nights (p = 0.022). This increased proportion with STEMI results in a greater proportion of ACS with AMI on weekends (up arrow 10%, p = 0.006) and nights (up arrow 7%, p = 0.033). Using multivariate modeling, the increase in patients with AMI on weekends was not explained by conventional risk predictors. Conclusions: Although fewer patients with ACS presented on nights and weekends, patients at those times were more likely to have an AMI, driven largely by an increased proportion with STEMI at those times. Consideration should be given to these findings when developing clinical care paradigms, health care staffing needs, and when comparing new treatment outcomes in patients with ACS.
引用
收藏
页码:542 / 546
页数:5
相关论文
共 50 条
  • [21] Revascularization in the acute coronary syndromes
    Labounty, Troy
    Eagle, Kim A.
    BIOLOGICAL RHYTHM RESEARCH, 2007, 38 (03) : 259 - 268
  • [22] Bivalirudin in acute coronary syndromes
    Galli, Mattia
    Bernardi, Marco
    Ortega-Paz, Luis
    Nerla, Roberto
    D'Amario, Domenico
    Franchi, Francesco
    Biondi-Zoccai, Giuseppe
    Angiolillo, Dominick J.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2023, 21 (12) : 901 - 911
  • [23] Guidelines for the acute coronary syndromes
    Rapaport E.
    Current Cardiology Reports, 2001, 3 (4) : 289 - 296
  • [24] Nine-year comparison of presentation and management of acute coronary syndromes in Ireland: A national cross-sectional survey
    Doyle F.
    De La Harpe D.
    McGee H.
    Shelley E.
    Conroy R.
    BMC Cardiovascular Disorders, 5 (1)
  • [25] Cardiac biomarkers and acute coronary syndromes - The Euro Heart Survey of Acute Coronary Syndromes Experience
    Hasdai, D
    Behar, S
    Boyko, V
    Danchin, N
    Bassand, JP
    Battler, A
    EUROPEAN HEART JOURNAL, 2003, 24 (13) : 1189 - 1194
  • [26] Psychometric evaluation of the Symptoms of Acute Coronary Syndromes Inventory in Chinese patients with acute coronary syndromes
    Li, Polly W. C.
    Lee, Diana T. F.
    Yu, Doris S. F.
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2014, 13 (04) : 295 - 303
  • [27] Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events
    Dey, S.
    Flather, M. D.
    Devlin, G.
    Brieger, D.
    Gurfinkel, E. P.
    Steg, P. G.
    FitzGerald, G.
    Jackson, E. A.
    Eagle, K. A.
    HEART, 2009, 95 (01) : 20 - 26
  • [29] Acute Coronary Syndromes without ST Segment Elevation
    Moellmann, Helge
    Nef, Holger
    Hamm, Christian W.
    HERZ, 2009, 34 (01) : 30 - 38
  • [30] Role of statin drugs in acute coronary syndromes.
    Rackley C.E.
    Current Atherosclerosis Reports, 2002, 4 (3) : 161 - 163